Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where André C. Knulst is active.

Publication


Featured researches published by André C. Knulst.


Mediators of Inflammation | 1994

Cytokine Detection and Modulation in Acute Graft vs. Host Disease in Mice

André C. Knulst; G. J. M. Tibbe; C. Bril-Bazuin; Elvera G Breedland; A. van Oudenaren; Robbert Benner; H. F. J. Savelkoul

A murine model for acute lethal graft vs. host disease (GVHD) was used to study the role that a number of cytokines play in the development of lethal GVHD. In this study we focused on the role of IL-1, IL-2, IL-4, IL-6, IFN-γ and TNF-α. Lethally irradiated (C57BL × CBA)F1 mice were reconstituted either with 107 allogeneic BALB/c spleen cells or with a similar number of syngeneic cells, as a control. A significant rise in serum levels of IL-6, TNF-α and IFN-γ levels was found in allogeneically reconstituted mice. This is in contrast to the syngeneic control group in which no rise was seen. Serum IL-2 and IL-4 levels were below the detection limit. In the supernatant of Con A stimulated spleen cells from allogeneically reconstituted mice IL-6, IFN-γ and TNF-α concentrations were increased. The expression of mRNA for cytokines as detected by reverse transcription PCR was studied in spleen cells. In the allogeneic reconstituted mice the mRNA expression of IL-1α, IL-2, IL-6, IFN-γ and TNF-α displayed faster kinetics compared with that in syngeneic reconstituted mice. The effect of treatment with recombinant cytokines, antibodies to cytokines and to cytokine receptors on the development of GVHD was investigated. Administration of recombinant IL-2 to allogeneically reconstituted mice strongly increased the morbidity and mortality whereas injection of IL-1α and TNF-α did not influence survival. Administration of antibodies against IL-2 or the IL-2 receptor decreased the morbidity and mortality. Anti-IL-6, anti-IFN-γ, and anti-TNF-α mAB, on the other hand, did not affect the morbidity and mortality of GVHD. The results of this study suggest successive waves of cytokine-secreting cell populations consistent with the induction of an inflammatory response in the development of acute GVH disease.


Immunobiology | 1989

MHC- and Igh-Unrestricted Interaction between L3T4+, Lyt-2- Ts Inducer Cells and L3T4-, Lyt-2+ Ts Effector Cells is Required for T Cell-Depend

A. Molendijk; Ruud J. H. L. M. van Gurp; André C. Knulst; Robbert Benner

This paper describes the characteristics of T suppressor inducer (Ts ind) cells which can interact with T suppressor effector (Ts eff) cells and thereby can account for suppression of delayed-type hypersensitivity (DTH) to alloantigens. Adoptive transfer of spleen cells from mice intravenously (i.v.) injected with allogeneic spleen cells one day earlier induced an antigen-specific state of suppression in the recipients. This became apparent when DTH was induced by subcutaneous (s.c.) immunization of the recipients three days after transfer. The induction of suppression after adoptive transfer of spleen cells required Thy-1+, L3T4+, Lyt-1+2- cells. These cells that by themselves did not exert a suppressive effect induced a state of suppression in recipient mice by activation of recipient-type Ts eff cells. Therefore, the former cell type was classified as Ts ind cell. When athymic nude mice were used as recipients, Lyt-2+ precursors of Ts eff cells had to be transferred together with the Ts ind cells to induce a state of suppression in these mice. The Ts ind cells could activate Ts eff cells in MHC- and Igh-incompatible recipients. The results are discussed in relation to previously described immunoregulatory T cell pathways.


Transplant International | 1992

Cytokines in lethal graft-versus-host disease

André C. Knulst; C. Bril-Bazuin; G. J. M. Tibbe; A. van Oudenaren; H. F. J. Savelkoul; Robbert Benner

Graft-versus-host disease (GVHD) is caused by donor T lymphocytes that recognize foreign antigens on host tissues. This leads to T cell activation, which involves a cascade of events including the transcription of genes for cytokines and their receptors and the production of cytokines. One of the first cytokines to appear is interleukin 2 (IL-2). IL-2 production enhances the IL-2 receptor expression and leads to T cell proliferation. As a further step, differentation of T cells occurs, which results in the production of a certain pattern of cytokines. These cytokines influence the expression of cell surface antigens and adhesion molecules, and are able to activate other cell types such as cytotoxic T cells, macrophages and natural killer cells, which might act as effector cells in tissue destruction. Insight into the sequential expression of the various cytokines involved might enable a more effective treatment of GVHD. Therefore, we investigated the occurrence of cytokines in a murine model for acute GVHD. We addressed in particular the period early after allogeneic reconstitution.


Transplant International | 1992

Prevention of lethal graft-versus-host disease by monoclonal antibody treatment in vivo

André C. Knulst; G. J. M. Tibbe; C. Bril-Bazuin; Robbert Benner

Graft-versus-host disease (GVHD) is a major complication of allogeneic bone marrow transplantation (BMT). The disease is caused by mature T cells in the graft that recognize foreign antigens of the host and subsequently elicit an immune response to host tissues. Although T-cell depletion of the graft strongly reduced the incidence and severity of GVHD, the overall survival of allogeneic BMT did not increase because of the increased rate of graft rejection and leukemic relapses. New prophylactic and therapeutic approaches have to be developed to improve the outcome of allogeneic BMT. T-cell-specific monoclonal antibodies (mAb) administered in vivo to the allograft recipients seem to be promising in the prevention and treatment of lethal GVHD. In this study we especially addressed the effect of in vivo treatment of recipients with anti-T-cell subset mAb in a murine model for acute GVHD. We also determined the long-term effects.


Immunobiology | 1988

Lipopolysaccharide-induced Suppression of Graft-versus-Host Reactivity in Mice

A. Molendijk; André C. Knulst; Ruud J. H. L. M. van Gurp; Adri van Oudenaren; Robbert Benner

Reconstitution of lethally irradiated mice with spleen cells from donors that had been treated with lipopolysaccharide (LPS) intravenously and allogeneic spleen cells subcutaneously leads to a suppressed anti-host delayed-type hypersensitivity (DTH). Either donor injection alone proved to be ineffective. The state of suppression appeared to be antigen-specific, but, depending on the experimental conditions, also anti-host DTH to third-party alloantigens could be suppressed. The suppression was mediated by a population of Thy-1- suppressor cells that could also be induced in athymic nude mice. The suppressor cells specifically adhered to anti-kappa-coated plastic plates, but were not adsorbed by passage through a Sephadex G-10 column. Thus, it appears that the combined donor treatment with LPS and allogeneic spleen cells induces a population of B cells that can suppress anti-host immune reactivity.


Transplantation | 1989

Blood transfusion-induced suppression of delayed-type hypersensitivity to allogeneic histocompatibility antigens.

André C. Knulst; Clara Bazuin; Robbert Benner


European Journal of Immunology | 1991

Prevention of lethal graft‐vs.‐host disease by a single low dose injection of anti‐T cell monoclonal antibody to the allograft recipients

André C. Knulst; C. Bril-Bazuin; Robbert Benner


Transplantation | 1994

Suppression of skin allograft rejection in mice by anti-CD3 monoclonal antibodies without cytokine-related side-effects

A.C.T.M. Vossen; André C. Knulst; G. J. M. Tibbe; A. van Oudenaren; M.R.M. Baert; Robbert Benner; H. F. J. Savelkoul


Transplantation | 1991

Suppression of graft-versus-host reactivity by a single host-specific blood transfusion to prospective donors of hemopoietic cells.

André C. Knulst; C. Bril-Bazuin; H. F. J. Savelkoul; Robbert Benner


European Journal of Immunology | 1992

Improved survival from potentially lethal graft‐vs.‐host disease by donor pretreatment with a recipient‐specific blood transfusion. I. Requirements for induction and specificity of the effect

André C. Knulst; C. Bril-Bazuin; G. John M. Tibbe; Robbert Benner

Collaboration


Dive into the André C. Knulst's collaboration.

Top Co-Authors

Avatar

Robbert Benner

Erasmus University Rotterdam

View shared research outputs
Top Co-Authors

Avatar

C. Bril-Bazuin

Erasmus University Rotterdam

View shared research outputs
Top Co-Authors

Avatar

G. J. M. Tibbe

Erasmus University Rotterdam

View shared research outputs
Top Co-Authors

Avatar

H. F. J. Savelkoul

Erasmus University Rotterdam

View shared research outputs
Top Co-Authors

Avatar

A. Molendijk

Erasmus University Rotterdam

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Csaba Vizler

Hungarian Academy of Sciences

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge